Plasma metabolites mediate the effect of HbA1c on incident cardiovascular disease

Abstract

Background We aim to discover whether HbA1c affects incident cardiovascular disease (CVD) through regulating endogenous metabolites. Methods and Results Totally, 2019 plasma samples were analyzed by liquid chromatography‐quadrupole time‐of‐flight mass spectrometry. Logistic regression and linear regression were used to screen metabolites which were associated with both CVD and HbA1c. The VanderWeele's mediation approach was performed to assess the direct effect and indirect effect (IE) in the counterfactual model. Forty‐eight metabolites showed an association with both HbA1c and CVD risk. Forty‐four of the 48 metabolites worked as mediators mediated in HbA1c's effect on CVD (odds ratio [OR]IE from 0.997 to 6.098, false discovery rate q < 0.05, mediated proportion from 0.4% to 85.4%). Pathway enrichment analysis indicated that different metabolic pathway showed significant IE (butanoate metabolism ORIE = 1.058, mediated proportion = 16.0%; alanine, aspartate and glutamate metabolism ORIE = 1.082, mediated proportion = 21.8%; TCA (citric acid) cycle metabolism ORIE = 1.048, mediated proportion = 13.8%; phenylalanine metabolism ORIE = 1.067, mediated proportion = 18.4%; glycerophospholipid metabolism ORIE = 3.007, mediated proportion = 82.2%; all the P < .01). Conclusions Our findings suggest that metabolites mediate the effect of HbA1c on incident CVD and provide a new study sight into pathogenesis of CVD.

Unraveling the Serum Metabolomic Profile of Acrylamide-Induced Cardiovascular Toxicity

“…This may indicate that high-dose acrylamide could cause oxidative damage. It is well known that high levels of GLU contribute to oxidative stress, which causes oxidative damage and dysfunction of the vascular endothelium as an indicator in many vascular diseases in the early stage . Notably, our study found that the concentration of GLU in the serum increased in a dose-dependent manner, indicating abnormal GLU metabolism and a higher risk of diabetes.…”

Serum Metabolomics Reveals Underlying Mechanisms of Cholesterol‐Lowering Effects of Oat Consumption: A Randomized Controlled Trial in a Mildly Hypercholesterolemic Population

“…Consistent with previous studies, this result indicated that the alanine, aspartate, and glutamate metabolism pathway is one mechanism of lipid regulation. [ 68,69 ]…”

“…Consistent with previous studies, this result indicated that the alanine, aspartate, and glutamate metabolism pathway is one mechanism of lipid regulation. [68,69] It is well known that lipoic acid can serve as an essential enzyme cofactor for -ketoacid dehydrogenase complexes) and play a vital role in cellular energy metabolism. Previous clinical trials and meta-analysis demonstrated a favorable effect of the lipoic acid supplement on lipids regulation, [70,71] while the results are mildly contradictory to the decreased concentrate of R-lipoic acid www.advancedsciencenews.com www.mnf-journal.com observed in the oat group this time.…”

Study of the Mechanism of Action of Guanxin Shutong Capsules in the Treatment of Coronary Heart Disease Based on Metabolomics

“…As important enzyme substrates and regulators, amino acids play important roles in many metabolic pathways, which contain important biochemical information reflecting the metabolic and functional state of the body and play important roles in the normal operation of the immune system and other organs (White and Newgard, 2019). Studies have shown that phenylalanine metabolic disorder is related to the aggravation of oxidative stress reactions, such as lipid peroxidation in the body (Dong et al, 2019). The oxidative stress reaction causes vascular endothelial oxidative damage and then leads to vascular endothelial dysfunction, which is an indicative response in the early stage of many cardiovascular diseases (Zhang et al, 2020).…”